Biogen Idec and Sunesis Sign Small Molecule Cancer Agreement
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 52 (Table of Contents)
Published: 4 Oct-2004
DOI: 10.3833/pdr.v2004.i52.766 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Biogen Idec and Sunesis entered into research and development agreement for Sunesis’ Tethering® drug discovery technology to develop and discover small molecules to target kinases for treating cancer...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS